VC
ONCT

Vestor Capital’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Vestor Capital’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-36
Closed -$69K – 88
2014
Q2 		$69K Hold
36
– – 0.02% 65
2014
Q1 		$77K Hold
36
– – 0.03% 66
2013
Q4 		$83K Buy
36
+15
+71% +$34.3K 0.03% 69
2013
Q3 		$61K Buy
+21
New +$104K 0.02% 69

Other funds holding ONCT

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Vestor Capital's ONCT Position: Q3 2014 in Review

Vestor Capital sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q3 2014, closing a stake of 36 shares — an estimated $69K sold.

Vestor Capital first reported a position in ONCT in Q3 2013 and held it in 4 quarters. The position peaked at $83K in Q4 2013. 38 funds tracked by Wall St. Rank hold ONCT as of Q3 2014.

  • Vestor Capital reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • Vestor Capital sold 36 Oncternal Therapeutics, Inc. Common Stock shares in Q3 2014, an estimated $69K.
  • Vestor Capital first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q3 2013 and held it in 4 quarters.
  • Vestor Capital's Oncternal Therapeutics, Inc. Common Stock position peaked at $83K in Q4 2013.
  • 38 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q3 2014.

Based on Vestor Capital's 13F filing for Q3 2014, filed 17 Nov 2014.